FDA Warnings: Mariposa Done With OTCs, Thibiant's Long Correction List
Executive Summary
GMP violations FDA inspectors found at Mariposa Labs' plant were repeats of a previous inspection. Thibiant International's problems included was "knowing the formulation was flawed" but making "a second batch using the same formulation."